{"transactions":[{"id":806891,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":52249,"kind":"person","name":"Smeal Tod","position":1,"cik":"0001904824","reported_name":"Smeal Tod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2026-04-16T20:03:06.000Z","date":"2026-04-14","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"75,000 vest on April 14, 2027 and 6,250 vest monthly for 36 months thereafter"}],"balance_after":1279805,"derivative":{"exercise_price":1.63,"expiration_date":"2036-04-14","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001904824-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000190482426000002/ownership.xml","form_type":"4"}},{"id":1207515,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":52249,"kind":"person","name":"Smeal Tod","position":1,"cik":"0001904824","reported_name":"Smeal Tod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2025-03-13T20:03:03.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":332621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 11, 2026 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":979805,"derivative":{"exercise_price":3.58,"expiration_date":"2035-03-11","underlying":"Common Stock","underlying_shares":332621},"source":{"system":"sec-edgar","filing":"0000950170-25-038698","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000095017025038698/ownership.xml","form_type":"4"}},{"id":1588855,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":52249,"kind":"person","name":"Smeal Tod","position":1,"cik":"0001904824","reported_name":"Smeal Tod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2024-03-07T23:39:51.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":205008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 7, 2025 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":647184,"derivative":{"exercise_price":3.51,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":205008},"source":{"system":"sec-edgar","filing":"0001628280-24-009746","document":"wk-form4_1709854782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828024009746/wk-form4_1709854782.xml","form_type":"4"}},{"id":1949816,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":52249,"kind":"person","name":"Smeal Tod","position":1,"cik":"0001904824","reported_name":"Smeal Tod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2023-03-16T21:42:28.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":167088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 15, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":442176,"derivative":{"exercise_price":1.72,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":167088},"source":{"system":"sec-edgar","filing":"0001628280-23-008357","document":"wf-form4_167900293568224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023008357/wf-form4_167900293568224.xml","form_type":"4"}}]}